Parascript Obtains Second CE Mark, This Time for Its AccuDetect Computer Aided Detection Software for Mammography

Parascript AccuDetect, designed to help radiologists in the early detection of hard-to-find breast cancers, gains acceptance for commercialization in the European Union on the heels of approval for sister product AccuDetect Galileo

Parascript, LLC, the image
analysis and pattern recognition technology provider, today announced that it received CE (Conformite Europeenne) Mark for AccuDetect(r) Computer Aided Detection (CAD) software. The company makes this announcement on the heels of obtaining CE Mark for its AccuDetect Galileo Computer Aided Detection (CAD) software, which uses the integration of two independent CAD systems to create a robust CAD solution with improved lesion detection rates and low false marks.

As with AccuDetect Galileo Computer Aided Detection software, AccuDetect CAD performs a computerized second read of mammography images to help radiologists confirm that a suspicious area requires further investigation. AccuDetect CAD is unique in that it uses a different methodology to achieve high sensitivity and low false positive rates through the integration of
several complimentary algorithms and a sophisticated voting scheme within a single CAD system. The two products complement each other and target unique customers and distribution channels.

"We are delighted to receive our second CE Mark, this time for AccuDetect CAD software for mammography," said Yuri Prizemin, director of product marketing for Parascript. "Parascript remains committed to raising the bar for next generation CAD systems, and we are pleased to be able to offer our AccuDetect to customers in the European Union."

Share:


Tags: CE mark, Mammography, Parascript


About Parascript LLC

View Website

Krystine Dinh
Press Contact, Parascript LLC